PDZD2 and thyroid cancer: We found that the high impact mutations in JMJD1C, SLA, PDZD2, identified from in-silico analysis in PTC samples, are missing in the thyroid cancer cell lines analyzed, thus suggesting that the altered expression of these genes is due to other regulative biological mechanisms.